Background: Knowing the risk factors and clinical manifestations of coronary artery disease (CAD) allows us to intervene more effectively with a particular population.
In elderly patients, percutaneous coronary intervention (PCI) is a strategy of revascularization often used 4, 5 . Observational data of the 90's suggested that elderly patients are a high-risk group for PCI 6, 7 , progressing to higher mortality rates when compared to younger individuals.
Elderly patients with acute coronary syndrome (ACS) often have different risk profile from non elderly: they have a higher prevalence of arterial hypertension, diabetes mellitus, myocardial infarctation, angina, peripheral vascular disease, cerebral vascular accident (CVA), multi artery disease and heart failure. On the other hand, they have lower cholesterol levels and a lower prevalence of smoking. Generally, the elderly search for medical care later, after the onset of symptoms. In the event of ACS, instead of pain, they frequently have the so-called "ischemic equivalents," such as dyspnea, malaise, confusion, syncope or pulmonary edema. Also in relation to non elderly, the elderly have lower elevation of cardiac enzymes and a higher incidence of ACS without STS
Introduction
The prevalence of coronary artery disease (CAD) has been progressively increasing worldwide as a result of increased life expectancy and survival to acute conditions. Facts that are also seen in Brazil 1 . Cardiovascular diseases have significant morbidity and mortality in the elderly. The World Health Organization (WHO) considers elderly in developing countries, those who are 60 years old or older and in developed countries, individuals aged 65 years old or older. In the U.S., the elderly constitute 13.0% of the population, which accounts for 65.0% of hospitalizations for heart disease. About 85.0% of deaths from AMI occur in the elderly population 2, 3 .
Methods

Sample selection
Hospital do Servidor Público serves patients from a service network covering the city of São Paulo and 18 
Analyzed characteristics
As per clinical presentation modalities of CAD, patients were characterized as stable angina (SA), ACS without ST-segment elevation (STS), ACS with STS or ischemic equivalent (atypical manifestations of ACS as dyspnea, malaise, confusion, syncope or pulmonary edema). Risk factors for CAD and its comorbidities were documented at the time of catheterization, by completing a questionnaire: diabetes mellitus (if present, the therapeutic regimen in use is specified: Insulin, oral hypoglycemic agents, diet), smoking, history of CAD in the family, cerebrovascular accident (CVA) /transient ischemic attack (TIA), chronic kidney failure (if present, treatment regimen of dialysis or conservative treatment), dyslipidemia, coronary history (if prior AMI, myocardium revascularization or PCI).
The angiographic characteristics such as extent of CAD (characterized by the number of vessels with angiographic lesion over 50.0% -one, two or three-arteries), TIMI flow before PCI (TIMI 0/1, or when there is absence or discrete flow distal to target lesion; TIMI 2, when there is flow distal to target lesion of the entire coronary, delayed, though; TIMI 3, when there is flow distal to target lesion of the entire coronary compatible with normality) and the treated vessel (if native coronary, venous/arterial or vessel graft with restenosis) were documented and analyzed.
Cardiac catheterization and percutaneous coronary intervention
PCIs were performed according to standard methods and guidelines orientations in force [11] [12] [13] . Angiographic and procedure success 11 was defined as: 1) angiographic: reduction of target stenosis to a stenosis diameter of < 30.0%, with maintenance or restoration of TIMI 3 flow, as assessed by quantitative coronary angiography; 2) procedure: achievement of angiographic success and absence of major clinical complications (death, AMI with STS and emergency myocardial revascularization surgery). The definition of AMI after a procedure takes into account the development of new Q waves and/or elevation of CK-MB (> three times its baseline), with or without associated precordialgia.
The coronary lesions were divided into A, B1, B2 and C 11 , according to the classification of the American College of Cardiology and American Heart Association. The characteristics of high risk (type C) were: lesion length > 20 mm, massive calcification, excessive tortuosity of proximal segment, target segment with extreme angulation (> 90 degrees), chronic occlusion in blunt tip, inability to protect significant lateral (≥ 2.5 mm) and stenotic (> 50%) branch, degenerated vein grafts.
In-hospital outcomes
Patients were followed up during hospitalization, with the intent to highlight complications associated with both diagnostic and therapeutic procedures, the latter being more frequent. The complications were categorized as major were death, myocardial infarctation, emergency MR and CVA (loss of neurological function of vascular cause that lasts longer than 24 hours). Minor complications were: access site complications, renal failure secondary to contrastinduced nephropathy (relative increase of 25 to 50.0% or absolute of 0.5 mg/dl of baseline creatinine after contrast exposure), adverse reactions to radiological contrast, TIA (focal neurological deficit of sudden onset lasting less than 24 hours, presumably of vascular origin and confined to one area of the brain, or eye, irrigated by a specific artery) 14 .
The medications used during hospitalization were prescribed by the physician in charge, being documented by completing the medical record, emphasizing: fractionated and low molecular weight heparin, tirofiban, ASA, clopidogrel, ticlopidine, nitrate, betablockers, calcium channel blocker, angiotensin converting enzyme inhibitor, nitrate, insulin, oral hypoglycemic agents 15 .
Statistical analysis
A total of 1,282 patients who underwent 1,410 cardiac catheterizations were evaluated for diagnosis clarification of CAD, and therapeutic clarification for treatment of coronary stenosis, according to inclusion and exclusion criteria.
Quantitative variables were presented as means and standard deviations and the absolute and relative frequencies for qualitative variables were calculated.
To compare the associations between clinical and angiographic variables and the occurrence of death, chi-square
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test or Fisher's exact test were used. The ages were divided into three age groups (< 60 years old, 60-74 years old and ≥ 75 years old).
To compare the distributions of creatinine clearance among patients younger than 75 years old or 75 years old or more nonparametric ANOVA Kruskal-Wallis was used.
To study the clinical and angiographic correlations and death, in a multivariate way, logistic regression model with stepwise variable selection process was used.
The significance level used was 5.0%.
Results
Overview of the study population
In the study period, 1,410 cardiac catheterizations were performed in 1,282 patients for CAD diagnostic clarification. Table 1 outlines the main baseline clinical characteristics of this population. 688 (54.0%) males, mean age of 65.4 years old (± 10.9) and 20.1% above 75 years old. Among the classic risk factors for CAD, the most common were systemic arterial hypertension and dyslipidemia. Diabetes mellitus was present in 31.6% of patients.
The confirmed clinic condition that triggered the most catheterization was ACS without STS (38.7%). Among AMI with STS, primary PCI was performed in only 19.0%; 77.0% were transferred from origin hospitals late (late PCI) and had not received prior thrombolytic, 4.0% underwent rescue PCI (Chart 1). Among patients who were not referred for primary PCI, only 12.0% of patients received thrombolytic treatment.
Multiartery coronary artery disease occurred in 46.4% of coronariographies, PCI was indicated in 464 patients and 547 treated target lesions (type B2 or C in 86.6%), located mostly in native vessels (94.7%) and treated with stents, 14.6% with drug-eluting stent (Table 2) .
Procedural success was achieved in 94.2% of PCIs. When analyzed by clinical situation, ACS patients without STS and those with STS undergoing angioplasty within the first 12 hours were successful in 97.1%, while patients with ACS with STS treated late (> 24 hours) and who kept clinical evidence of ischemia, such as post-infarctation angina, acute pulmonary edema attributed to ischemia, among other presentations considered by the clinician of the patient as a result of ischemia, were successful in 90.4%. Among patients with stable angina and atypical manifestations of CAD, the procedural success was achieved in 97.2% and 100.0% respectively.
AMI after PCI was observed in 2.8% of patients, among these, one patient with acute thrombosis (first 24 hours after PCI) of eluting stents (Supralimus 2.5 x 39 mm), possibly due to the stent hypoexpansion in a portion of the lesion with severe calcification of the artery. There was no need for emergency MR (Table 3) .
Among patients undergoing coronary angiography, renal failure secondary to contrast-induced nephropathy occurred in 20 patients (1.6%), of which one quarter required dialysis as therapy. Bleeding from the arterial access way occurred in one patient (femoral), requiring blood transfusion. It was not observed pseudoaneurysm at the puncture site and was not observed inferior or superior limb ischemia (in the case of the radial procedure), ischemic or hemorrhagic CVA.
Death after PCI occurred in 5.2%, mean age of 75.2 ± 10.2 years old. The number of vessels affected by severe lesions was associated with in-hospital mortality: one, two, three vessels or left trunk coronary had a mortality rate of 0.54%, 3.33% and 3.41% respectively (p = 0.0005).
The most used drugs by the patients at the time of catheterization (Table 4) were ASA (65.7%) and statin (52.3%). Overall, patients undergoing PCI received dual antiplatelet therapy (ASA and clopidogrel) after the angioplasty (97.3%).
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Chart 1 -Percutaneous coronary intervention modalities used in the ACS with STS* treatment; *ACS with STS -acute coronary syndrome with ST-segment elevation.
Hospital stay was longer in patients with clinical symptoms of ACS (13.7 days).
Comparative analysis between patients younger than 75 years old and older than or equal to 75 years old Patients who are 75 years old or older had creatinine clearance (CrCL) lower than the patients younger than 75 years old (42.06 and 68.18 l/min/1.73m 2 , respectively, p < 0.00001). In comparison with males, the female patients undergoing cardiac catheterization were older.
Mortality among those over 75 years old was higher than in those under 75 years old (5.0% versus 1%, p = 0.000097), as in previous CRF (5.3% versus 1.3%, p = 0.0028), as seen in Table 5 . All deaths were in patients with ACS (with ST = 37.5%; without ST elevation = 62.5%).
Discussion
The present study is the first report on clinical and angiographic characteristics of the population of servers in According to data from Fundação Seade, the number of elderly people in São Paulo state is 4.3 million and from this total, 1.9 million is composed of persons aged 70 or older (www.seade.org.br ). In 2020, there will be 7.1 million elderly people in São Paulo state, from this total, consisting of 2.9 million people aged 70 or more. Hence, the great importance of epidemiological studies showing prevalence of elderly population.
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One of the most important observations was the large number of patients with ACS without ST elevation (38.7%) in a general hospital, a figure comparable to the 40.0% of emergency centers in cardiology 16 . The coronary angiography allows the precise identification of the extent and severity of coronary obstructions, complements the prognostic stratification and the identification of the most appropriate treatment (medical, surgical or percutaneous revascularization), regarding the coronary anatomy presented angiographically.
Two strategies emerge for the treatment of these patients: an early invasive strategy, coronariography within 72 hours, and conservative strategy, after 72 hours of hospital admission 17, 18 . Although there is not unanimity on the best strategy, the most recent evidence supports an early invasive strategy. All these trials support the prescription of the "invasive strategy" because it reduced the mortality and the occurrence of late infarctation such as re-hospitalization due to ACS [18] [19] [20] [21] .
On this record, we applied the early invasive strategy to identify patients at highest risk, as patients with severe multi artery CAD (23.0%) and stenoses in left coronary trunk (2.0%). Despite this conduct, we observed a delay in the indication for catheterization, and the patient was referred to the hemodynamics frequently only when admitted to the coronary care unit or cardiology ward, after evaluation by a cardiologist. Such conduct is possibly reflected in a longer period of hospitalization.
In patients with ACS with STS, the elapsed time between the onset of pain and coronary recanalization, chemical or mechanical, is the fundamental factor for the benefit of treatment, both immediate and late, considering the relationship with mortality and morbidity in patients treated within 12 hours of onset of pain. Concerning, in relation to patients with such diagnosis transferred from other hospitals, is the fact that they do not receive appropriate reperfusion therapy, either by delay in transferring or no previous administration of thrombolytic therapy (only 19.0% of primary PCI in the first 12 hours and 12.0% of thrombolytic therapy in this record). This fact affected the success rate of the procedure as described in the results, since patients undergoing PCI within the first 12 hours were successful in 97.1% and those who underwent late PCI, 90.4% (PCI was performed, as, according to the clinical condition of patients, there was clinical myocardial ischemia evidence).
Studies have shown that PCI elective prescription for an occluded coronary artery within one to 28 days after the AMI occurrence in stable patients, did not provide any benefit greater than that offered by medical therapy consisting of aspirin, betablockers, angiotensin converting enzyme inhibitors and statins in preserving left ventricular contractile function and new cardiovascular events 22, 23 . The population served in HSPE-FMO, IAMSPE is characterized by the prevalence of elderly patients and patients over 70 years old account for approximately 30.0% of the admissions information of great importance since such patients are often excluded from clinical trials 34 . It can also evaluate the use and adherence to the medical therapeutic procedures 34, 35 . With this record, we describe a specific population, presenting your profile and how it has led to the diagnosis of CAD research and treatment of this clinical entity in light of the recommended guidelines and numerous clinical trials.
Literature data have shown the benefits of primary PCI, compared to fibrinolysis. Primary PCI is capable of restoring normal epicardial coronary flow (TIMI grade 3) in more than 90.0% of patients, which is associated with reduced rates of recurrent ischemia and re infarctation, without the risk of severe bleeding complications, such as CBA [24] [25] [26] .
Groups of patients considered as high risk, such as the elderly, often have an indication of coronary angiography delayed or prevented, in evident contradiction to literature 27, 28 . This strategy deprives these patients of the possibility of treatment, as they would have greater benefit in early revascularization, reflected in mortality and/or re infarctation rates. This behavior seems to occur in this record, considering the average age of 65.4 years old (± 10.9) of patients undergoing catheterization, being 20.1% aged 75 years or more.
In CSA, the elderly have a higher incidence of complications, which implies the need for more intensive treatment. However, especially for those above 75 years old, often the best therapy, with beta-blockers, ASA, anticoagulant and hypolipemiant is not used 9, 29 . During in-hospital period, this difference in drug prescription was not observed in this record.
Our study found that among patients undergoing PCI, those aged 75 years old or more had a higher mortality, although the angiographic success was similar for persons under 75 years old. Complications remain more common in older patients, the prevalence of post-procedure renal failure due to contrastinduced nephropathy was consistent with the literature. Mehran et al 30 assessed the risk factors for contrast-induced nephropathy, determining a score for stratification of risk for the development of acute renal failure after PCI. Whereas the elderly population has reduced glomerular filtration rate, it is presumed that the contrast-induced nephropathy would occur more often in this group of individuals. Although this event can be anticipated, the related morbidity is still significant, making this risk considered in indicating the procedure. In cases of patients with high probability for contrast-induced nephropathy, prophylactic measures such as hydration, use of low molecular weight contrast and alternative measures, such as hydration and bicarbonate 31 and acetylcysteine 32 , should be considered.
The increased risk of developing acute renal failure has also been reported in patients with chronic renal failure with ACS with STS undergoing early PCI 33, 34 . In this group of patients, prophylaxis of acute renal failure can be done, and usually it is possible to obtain clinical stability of patients before intervention, unlike patients with ACS with STS who underwent primary PCI, when prior hydration is not possible and the hemodynamic instability is more common. Our record has identified that patients with chronic renal failure had higher in-hospital mortality, despite renal preparation accomplish and avoidance of the early invasive strategy in these patients.
Elderly patients are more often multiarterial disease. The survival time decreases with the involvement of additional vessels, with the involvement of the anterior descending and left ventricular dysfunction 35, 36 .
Our analysis shows that both younger and elderly patients can benefit from the PCI, with high rates of success, a fact that has also been observed by other authors 37, 38 . Age can not be considered a limiting factor for percutaneous procedures.
Conclusion
In this population, there is a predominance of elderly, 20.1% above 75 years old and male. Among the risk factors for CAD, the most common ones were systemic arterial hypertension and dyslipidemia. There was a predominance of acute coronary syndrome. Age greater than or equal to 75 years old, multiarterial CAD and chronic renal failure were predictors of in-hospital deaths in patients undergoing PCI.
Patients aged 75 years or more showed clinical/angiographic high-risk and rate of procedural success similar to younger patients, showing that the PCI is a technique safe and effective in this group of patients.
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